← Funding directory

Dated funding evidence

Nivoda

Series B · $30M (also reported as £24M / €27.9M) · 2024-05-10

Reported round$30M (also reported as £24M / €27.9M)Series B
Disclosure date
2024-05-10
Reported currency
USD
Companies House
10736332
Evidence sources
3

Company

NivodaCH 10736332
2024-05-10Series B$30M (also reported as £24M / €27.9M)

Resolved investor records

Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.

SourceVC research snapshot; Live Chris T D1Date2024-05-10Matchfunding_id joined to resolved canonical companyStatepublished

Record fields

What the source states

Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.

Round ID
FR-00429
Stage
Series B
Round name
Series B
Amount
$30M (also reported as £24M / €27.9M)
Lead investors
Avenir Growth Capital
Other investors
Headline, Abstract Ventures, Canaan Ventures
Source layers
VC research snapshot, Live Chris T D1
Snapshot
2026-08-15

Named evidence

Source trail

This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.

A 37X Ventures portfolio site

Operated by 37x Limited, a Guernsey Non Cellular Company, company number CMP76157, incorporated 18 July 2025.

Registered office: Les Echelons Court, Les Echelons, St. Peter Port, Guernsey, GY1 1AR.

Full company details